DUBLIN--(BUSINESS WIRE)--The "North America HLA Typing Transplant Diagnostics Services Market_, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. North America HLA typing transplant diagnostics services is expected to register a healthy CAGR in the forecast period 2018 to 2025.
The major factors contributing to the growth of the market includes factors such as technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures and increased research grants, funds, and public-private investments.
The North America HLA typing transplant diagnostics services market is segmented on the basis of technology into polymerase chain reaction (PCR) and next-generation sequencing (NGS). In 2018, Polymerase Chain Reaction (PCR) is expected to dominate the hospital LIMS market with 52.0% market share growing at a CAGR of 8.6% in the forecast period 2018 to 2025. However, next-generation sequencing (NGS) segment is expected to grow at the highest CAGR in the forecast period.
The North America HLA typing transplant diagnostics services market is segmented on the basis of technique into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide) and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the market with highest market share and is growing at a healthy CAGR in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) market segment is expected to grow at the highest CAGR in the forecast period.
The North America HLA typing transplant diagnostics services market is segmented on the basis of end-users into hospitals, transplant centers, specialty clinics and academic institutes. In 2018, on-premise hospital LIMS is expected to dominate the hospital LIMS market in the forecast period 2018 to 2025. However, hospitals market segment is expected to grow at the highest CAGR and is expected to reach USD 185.24 million in 2025.
Key Topics Covered
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. North America HLA Typing Transplant Diagnostics Services Market, By Technology
7. North America HLA Typing Transplant Diagnostics Services Market, By End-User
8. North America HLA Typing Transplant Diagnostics Services Market, By Geography
9. North America HLA Typing Transplant Diagnostics Services Market, Company Landscape
10. Company Profiles
- Thermo Fisher Scientific Inc.
- Proimmune Ltd.
- Laboratory Corporation of America Holdings
- Creative Biolabs
- Histogenetics LLC
- THE UCLA Immunogenetics Center
- Admera Health
- Quick Biology
- NEW YORK Blood Center
- The Sequencing Center
- Bloodcenter of Wisconsin
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/t2mvcn/north_america_hla?w=4
